Back to search results

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Systemic Lupus Erythematosus · Lupus Nephritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of California Irvine, Orange, California, United States

    Contact: Study coordinator (Alpha Clinic) · alphaclinic@uci.edu · 949-824-3990
    Contact: Principal Investigator (Priyanka Iyer, MD)

  • UC Davis Health, Sacramento, California, United States

    Contact: Study coordinator (Tammy Yotter) · tkyotter@ucdavis.edu · 916-734-8036
    Contact: Principal Investigator (Gaurav Gulati, MD)

  • Yale University, New Haven, Connecticut, United States

    Contact: Study coordinator (Fotios Koumpouras, M.D.) · fotios.koumpouras@yale.edu · 203-785-6823
    Contact: Principal Investigator (Fotios Koumpouras, M.D.)

  • University of Florida Health, Gainesville, Florida, United States

  • Mayo Clinic, Jacksonville, Florida, United States

    Contact: Study coordinator (Wesley Dillinger) · Dillinger.wesley@mayo.edu · 904-953-3626
    Contact: Principal Investigator (Vikas Majithia, MBBS, MPH)

  • Emory University, Atlanta, Georgia, United States

    Contact: Study coordinator (John Varghese) · john.varghese@emory.edu · 404-727-2886
    Contact: Principal Investigator (Arezou Khosroshahi, MD)

  • Northwestern Memorial Hospital, Chicago, Illinois, United States

    Contact: Study coordinator (Kaitlin King) · autoimmunesct@nm.org · 312-695-0990
    Contact: Principal Investigator (Irene Blanco, MD)

  • The University of Chicago Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Dr. Cuoghi Edens, MD, FAAP) · cedens@bsd.uchicago.edu · 773-702-6119
    Contact: Principal Investigator (Dr. Cuoghi Edens, MD, FAAP)

  • University of Kansas Medical Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Theresa Howard) · thoward2@kumc.edu · 913-588-0653
    Contact: Principal Investigator (Kimberly Liang, MD)

  • Tufts Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Latoya Marshall) · latoya.marshall@tuftsmedicine.org · 617-636-5409
    Contact: Study coordinator (Angela Chavez) · angela.chavez@tuftsmedicine.org · 617-636-7651
    Contact: Principal Investigator (Andreas Klein, MD)

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Ben Bennett) · mgbennett@mgh.harvard.edu · 617-643-4395
    Contact: Principal Investigator (Meghan Sise, MD)

  • Boston Children's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Bridget Kerwin) · BridgetO_Kerwin@DFCI.HARVARD.EDU · 617-632-5309
    Contact: Study coordinator (Joyce Chang, MD) · Joyce.Chang@childrens.harvard.edu · 617-355-6117
    Contact: Principal Investigator (Susan Prockop, MD)

  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Sydney Chase) · Schase9@bwh.harvard.edu · 617-525-7638
    Contact: Principal Investigator (Elena Massarotti, MD)

  • UMass Memorial Hospital, Worcester, Massachusetts, United States

    Contact: Study coordinator (Cancer Research Office) · cancer.research@umassmed.edu · 508-856-3216
    Contact: Principal Investigator (Roberto Caricchio, MD)

  • University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Patrick Nachman, MD) · pnachman@umn.edu · 612-624-9444
    Contact: Principal Investigator (Patrick Nachman, MD, FASN)

  • Columbia University Irving Medical Center, New York, New York, United States

  • University of Rochester, Rochester, New York, United States

    Contact: Study coordinator (Tyler Cavin) · Tyler_Cavin@URMC.Rochester.edu · 585-273-2720
    Contact: Principal Investigator (Christopher Palma, MD, ScM)

  • UNC Chapel Hill, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Shruti Saxena Beem) · shruti_saxena@med.unc.edu · 919-966-0545
    Contact: Study coordinator (Roger Huamani) · roger_huamani@med.unc.edu · 919-966-5688
    Contact: Principal Investigator (Saira Sheikh, MD)

  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

    CARTintake@chop.edu · CARTintake@chop.edu
    CARTNurseNavigator@chop.edu · CARTNurseNavigator@chop.edu
    Contact: Principal Investigator (Caitlin Elgarten)

  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Melissa Cunningham, MD, PhD) · lupusresearch@musc.edu · 866-859-6107
    Contact: Principal Investigator (Melissa Cunningham, MD, PhD)

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Doris Soebbing, BS, RN, BSN) · DRSoebbing@mdanderson.org · 832-247-8094
    Contact: Principal Investigator (Biruh Workeneh, MD, FASN)

  • Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada

    Contact: Study coordinator (Karine Chaussé) · karine.chausse.cemtl@ssss.gouv.qc.ca · 514-252-3400
    Contact: Principal Investigator (Caroline Lamarche, MD)

  • Clinica Universitaria de Navarra, Pamplona, Navarre, Spain

    Contact: Study coordinator (José Mora) · jmora@unav.es · +34948255400
Study leads

  • Medical Director

    Study Chair

    Cabaletta Bio

View source on ClinicalTrials.gov(opens in a new tab)